Heterologous Immunity between Adenoviruses and Hepatitis C Virus (HCV): Recombinant Adenovirus Vaccine Vectors Containing Antigens from Unrelated Pathogens Induce Cross-Reactive Immunity Against HCV Antigens
Host immune responses play an important role in the outcome of infection with hepatitis C virus (HCV). They can lead to viral clearance and a positive outcome, or progression and severity of chronic disease. Extensive research in the past >25 years into understanding the immune responses agai...
Main Authors: | Babita Agrawal, Nancy Gupta, Satish Vedi, Shakti Singh, Wen Li, Saurabh Garg, Jie Li, Rakesh Kumar |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-05-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/8/5/507 |
Similar Items
-
Heterologous Immunity and Hepatitis C Virus: Impact on Natural Infection, Pathogenesis and Vaccine Design
by: Babita Agrawal, et al.
Published: (2020-06-01) -
Adenovirus Biology, Recombinant Adenovirus, and Adenovirus Usage in Gene Therapy
by: Maki Watanabe, et al.
Published: (2021-12-01) -
Construction of recombinant adenovirus-5 vector to prevent replication-competent adenovirus occurrence
by: Wenbo Xie, et al.
Published: (2023-12-01) -
Dose Effects of Recombinant Adenovirus Immunization in Rodents
by: Eric A. Weaver
Published: (2019-10-01) -
Investigation of rotavirus and enteric adenovirus antigens in children between 0-14 years old
by: Fatma Avcioglu, et al.
Published: (2020-12-01)